Loading clinical trials...
Loading clinical trials...
Phase 1B/2A Study of the Safety and Tolerability of Human Neural Stem Cells for Huntington's Disease
Conditions
Interventions
hNSC-01
Locations
1
United States
University of California, Irvine
Irvine, California, United States
Start Date
April 6, 2026
Primary Completion Date
June 1, 2028
Completion Date
January 1, 2031
Last Updated
April 13, 2026
NCT06826612
NCT07253038
NCT04012411
NCT05326451
NCT03233646
NCT06774443
Lead Sponsor
Leslie Thompson
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions